Germline and tumor BRCA1/2 pathogenic variants in Chinese triple-negative breast carcinomas

被引：0
|
作者：
Gang Ji
Longlong Bao
Qianlan Yao
Jing Zhang
Xiaoli Zhu
Qianming Bai
Zhiming Shao
Wentao Yang
Xiaoyan Zhou
机构：
[1] Fudan University Shanghai Cancer Center,Department of Pathology
[2] Fudan University Shanghai Cancer Center,Department of Breast Surgery
[3] Shanghai Medical College,Department of Oncology
[4] Fudan University,Institute of Pathology
[5] Fudan University,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2021年 / 147卷
关键词：
Triple-negative breast cancer (TNBC); Somatic mutation; Large genomic rearrangement (LRG);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2935 / 2944
页数：9
相关论文
共 50 条
  • [1] Germline and tumor BRCA1/2 pathogenic variants in Chinese triple-negative breast carcinomas
    Ji, Gang
    Bao, Longlong
    Yao, Qianlan
    Zhang, Jing
    Zhu, Xiaoli
    Bai, Qianming
    Shao, Zhiming
    Yang, Wentao
    Zhou, Xiaoyan
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (10) : 2935 - 2944
  • [2] A Case of Triple-Negative Breast Cancer with Germline Pathogenic Variants in Both BRCA1 and BRCA2
    Kitahara, Miyuki
    Hozumi, Yasuo
    Machinaga, Mitsuki
    Hayashi, Yuka
    [J]. CASE REPORTS IN ONCOLOGY, 2021, 14 (03): : 1645 - 1651
  • [3] Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer
    Wong-Brown, Michelle W.
    Meldrum, Cliff J.
    Carpenter, Jane E.
    Clarke, Christine L.
    Narod, Steven A.
    Jakubowska, Anna
    Rudnicka, Helena
    Lubinski, Jan
    Scott, Rodney J.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2015, 150 (01) : 71 - 80
  • [4] Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer
    Michelle W. Wong-Brown
    Cliff J. Meldrum
    Jane E. Carpenter
    Christine L. Clarke
    Steven A. Narod
    Anna Jakubowska
    Helena Rudnicka
    Jan Lubinski
    Rodney J. Scott
    [J]. Breast Cancer Research and Treatment, 2015, 150 : 71 - 80
  • [5] Adolescent triple-negative breast cancer with germline pathogenic variants in both BRCA1 and TP53 genes: A case report
    Chen, Dongmei
    Zhang, Chenyang
    Yuan, Mengqi
    Zhang, Ying
    Liu, Qing
    Wan, Donggui
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [6] Transcriptoma analyses in triple-negative breast cancer with BRCA1 germline mutation
    Nakamura, Kivvi Duarte
    Ferreira, Elisa
    Ramalho, Rodrigo
    Brianese, Rafael
    Carraro, Dirce
    [J]. CANCER RESEARCH, 2017, 77
  • [7] Prognostic impact of germline BRCA1/2 pathogenic variants in breast cancer
    Corso, Giovanni
    Girardi, Antonia
    Calvello, Mariarosaria
    Gandini, Sara
    Gaeta, Aurora
    Marabelli, Monica
    Magnoni, Francesca
    Veronesi, Paolo
    Guerrieri-Gonzaga, Aliana
    Bonanni, Bernardo
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2023, 197 (01) : 103 - 112
  • [8] Prognostic impact of germline BRCA1/2 pathogenic variants in breast cancer
    Giovanni Corso
    Antonia Girardi
    Mariarosaria Calvello
    Sara Gandini
    Aurora Gaeta
    Monica Marabelli
    Francesca Magnoni
    Paolo Veronesi
    Aliana Guerrieri-Gonzaga
    Bernardo Bonanni
    [J]. Breast Cancer Research and Treatment, 2023, 197 : 103 - 112
  • [9] Characteristics of Chinese breast cancer patients with double heterozygosity for BRCA1 and BRCA2 germline pathogenic variants
    Wen, Song
    Zhang, Meng
    Chen, Jiuan
    Hu, Li
    Sun, Jie
    Yao, Lu
    Xu, Ye
    Zhang, Juan
    Xie, Yuntao
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2024,
  • [10] BRCA1 methylation in triple-negative breast cancer
    Kawachi, A.
    Okochi-Takada, E.
    Shimoi, T.
    Shimomura, A.
    Kodaira, M.
    Yunokawa, M.
    Yonemori, K.
    Shimizu, C.
    Fujiwara, Y.
    Ushijima, T.
    Tamura, K.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 28 - 29
12345